The world of health devices and therapy is evolving faster than ever and 2024 is shaping up to be a groundbreaking year From wearable tech that monitors your vitals in real time to cutting-edge therap ...
Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for ...